Skip to main content




) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.9%. By the end of trading, Pfizer rose 47 cents (2.1%) to $23 on average volume. Throughout the day, 31 million shares of Pfizer exchanged hands as compared to its average daily volume of 35.9 million shares. The stock ranged in a price between $22.71-$23 after having opened the day at $22.83 as compared to the previous trading day's close of $22.53. Other companies within the Health Care sector that increased today were:

Prima Biomed Ltd. ADR



), up 43.4%,

Ampio Pharmaceuticals



), up 28.9%,

K-V Pharmaceutical Company



), up 21.7%, and

TheStreet Recommends

Iridex Corporation



), up 21.6%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide. Pfizer has a market cap of $169.31 billion and is part of the


industry. The company has a P/E ratio of 21.1, above the average drugs industry P/E ratio of 18.1 and above the S&P 500 P/E ratio of 17.7. Shares are up 4.5% year to date as of the close of trading on Thursday. Currently there are 15 analysts that rate Pfizer a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Pfizer as a


. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,

Sunshine Heart



), down 27.6%,

CombiMatrix Corporation



), down 19%,

Anthera Pharmaceuticals



), down 16.1%, and




), down 15.4%, were all losers within the health care sector with

Warner Chilcott



) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care